Similar articles

• Diagnosis and treatment in metastatic adenocarcinoma of unknown primary tumour.

  Taal BG, Veenhof CH, Blijham GH, Neijt JP. Taal BG, et al. Neth J Med. 1988 Apr;32(3-4):204-11. Neth J Med. 1988. PMID: 3283582 Review. No abstract available.
• Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: long-term results with cisplatin-based chemotherapy.

  Greco FA, Hainsworth JD. Greco FA, et al. Semin Oncol. 1994 Oct;21(5 Suppl 12):77-82. Semin Oncol. 1994. PMID: 7992071 Review.
• [The chemotherapy of metastases of unknown origin].

  Shparyk IaV, Bilyns'kyĭ VT. Shparyk IaV, et al. Lik Sprava. 1996 Jan-Feb;(1-2):45-52. Lik Sprava. 1996. PMID: 9005104 Review. Ukrainian. No abstract available.
• [A successful combination therapy with resection and infusion chemotherapy for a patient with metastases from cancer of unknown origin].

  Nakagawa Y, Todoroki T, Koike N, Kawamoto T. Nakagawa Y, et al. Gan To Kagaku Ryoho. 2003 Mar;30(3):423-6. Gan To Kagaku Ryoho. 2003. PMID: 12669405 Japanese.
• Management of carcinoma of unknown primary site (CUP), any changes?

  Hansen HH, Daugaard G. Hansen HH, et al. Ann Oncol. 2001 Apr;12(4):431-2. doi: 10.1023/a:1011192414615. Ann Oncol. 2001. PMID: 11398871 No abstract available.